This message was sent to ##Email##
|
|
|
|
|
| |
Phys.Org
Researchers at Purdue University are creating a device that they hope will help identify risk factors that cause breast cancer.
The device, known as risk-on-a-chip, is a small plastic case with several thin layers and an opening for a piece of paper where researchers can place a portion of tissue. This tiny environment produces risk factors for cancer and mimics what happens in a living organism.
"We want to be able to understand how cancer starts so that we can prevent it," said Sophie Lelièvre, a professor of cancer pharmacology at Purdue.
READ MORE
ACS-NCDB
The National Cancer Database (NCDB) announces that the Participant User File (PUF) application is now open. The NCDB is accepting applications for site-specific files, which include cases diagnosed between 2004 and 2015, through Sept. 18. For more information, review the PUF website. Questions regarding the NCDB PUF or the RFA process for a PUF may be directed to NCDB technical staff at NCDB_PUF@facs.org.
Cure
Patients with advanced gastric cancer tend to use their health care resources more often and have a worse quality of life than those without the disease, according to a study whose results were presented Sept. 9 at the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain. The findings point to the need for new treatment options for this population, the authors concluded.
READ MORE
|
Promoted by
|
|
|
|
 |
Healthcare IT News
A new survey from technology provider Integra Connect has found that a majority of specialty physicians have yet to make the necessary organizational, IT or service investments to achieve success under MACRA success.
Integra Connect, which provides services for value-based specialty care, conducted the survey among attendees of the company’s June meeting in Atlanta. The respondents’ practices represented about 800 physicians, 58 percent of which were from oncology practices and 42 percent were from urology practices.
For starters, 100 percent of survey respondents admitted they have not yet fully grasped MACRA's impact on their practices.
READ MORE
Cancer Research UK
A drug that exploits genetic weaknesses in cancer cells can delay some advanced ovarian cancers from getting worse, according to unpublished clinical trial results.
Findings from the phase 3 ARIEL3 trial showed that rucaparib (Rubraca) – a type of PARP inhibitor – boosted the length of time before patients’ disease returned by many months. Professor Jonathan Ledermann, who led the study at the Cancer Research UK and UCL Cancer Trials Centre, described the findings as a “very important step forward for women with advanced ovarian cancer”.
The findings will be presented at the 2017 ESMO Congress in Madrid.
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text. Click here to learn more!
|
|
Cure
A new tool is helping health care providers determine who will benefit from palliative care starting early in the course of their treatment for cancer, according to the authors of a pilot study whose results were presented Sept. 9, during the 2017 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
The “Triggers” tool was developed by the London Cancer Alliance and is currently being piloted at the Royal Marsden NHS Foundation, a cancer treatment center in London. Health care professionals can assess the needs of their patients and determine if they are a good fit for palliative care, to be given alongside active treatment.
READ MORE
IFL Science
People with red hair are known for their fiery locks, freckles, and pale skin. However, one unfortunate side effect of these features is an increased risk of developing skin cancer, especially melanoma. Now, by discovering the link between red hair and cancer risk, scientists have worked out a way to potentially protect people from the disease.
READ MORE
 |
|
Novodiax is soon bringing to market 10-minute fast, sensitive and simple Immunoassay (IHC) kits for in vitro diagnostic use to address unmet needs in the intraoperative surgical oncology sector. Learn More
|
|
ACS Cancer Programs
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage your program to promote Breast Cancer Awareness Month and use it as an opportunity to display and publicize your accreditation status. To help you promote this event within your program and community, the NAPBC and the CoC have created a poster that you can download and print.
Access the poster as follows:
Centers solely accredited by NAPBC: Use the link to the Marketing Resources website provided in your performance report cover letter.
Programs that are accredited by the CoC solely and/or both the CoC and NAPBC: Go to CoC Datalinks and click on Marketing CoC Accreditation.
Please let us know about your celebration by sending photos and event information to
Susan Rubin, Business Development Manager, ACS Cancer Programs.
|
Promoted by
|
|
|
|
 |
Medical Xpress
Researchers at McMaster University have learned more about the regulation of a cellular signalling pathway involved in the development of several types of cancer, including colon cancer. The research provides insight into how the pathway – called the Wnt signalling pathway – works in normal stem cells, which helps determine what promotes disease states. The study was recently published in the journal Cell Reports.
READ MORE
AJCC
Donna Gress, RHIT, CTR of the American Joint Committee on Cancer (AJCC) has recorded a series of webinars developed for and delivered to the National Program of Cancer Registries (NPCR) Education Training Coordinators (ETC). NPCR has agreed to share these recordings and handouts with the registrar community. These webinars provide information on the assignment of stage, clarification of classification criteria with procedure/treatment differences and special concerns and highlight:
- Exceptions for T, N and M
- When biopsy is considered clinical vs. pathologic
- Review and examples of when to use blank vs. X
- Details based on common questions related to the anatomic site
- Case scenario, sometimes highlighting missing or incomplete information
Click here to start reviewing the webinars.
Webinars are free. Continuing education (CE) hours were not pre-approved for these webinars.
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more.
|
|
Cancer Research UK
Men with prostate cancer that has spread who are starting long-term hormone therapy may benefit from either of two additional treatments, according to unpublished clinical trial results. The results, based on analysis of data from the Cancer Research UK-funded STAMPEDE trial, show that standard hormone therapy combined with another hormone therapy called abiraterone (Zytiga) or a chemotherapy drug called docetaxel give comparable improvements in survival compared to standard hormone therapy alone.
READ MORE
ACS
Registration is now open for the American College of Surgeons Clinical Congress 2017, Oct. 22–26 in San Diego. Clinical Congress is one of the largest meetings of surgeons in the world and offers outstanding educational opportunities for every stage of your career. The theme of this year's conference is Do What's Right for the Patient.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
